Allergy Therapeutics Revenue and Competitors

Worthing, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Allergy Therapeutics's estimated annual revenue is currently $92.9M per year.(i)
  • Allergy Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Allergy Therapeutics has 462 Employees.(i)
  • Allergy Therapeutics grew their employee count by 5% last year.

Allergy Therapeutics's People

NameTitleEmail/Phone
1
Head Clinical OperationsReveal Email/Phone
2
Head Human ResourcesReveal Email/Phone
3
Head BD&L (EMEA)Reveal Email/Phone
4
Head Data Management and AnalyticsReveal Email/Phone
5
Head Corporate Medical Expertise and ComplianceReveal Email/Phone
6
Head Corporate Pharmacovigilance / Global Leading QPPVReveal Email/Phone
7
Director OperationsReveal Email/Phone
8
Human Resources DirectorReveal Email/Phone
9
Director Global Market Access & Scientific AffairsReveal Email/Phone
10
Chief Commercial Officer (CCO)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Allergy Therapeutics?

Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market. We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside of allergy are also under evaluation.

keywords:N/A

N/A

Total Funding

462

Number of Employees

$92.9M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Allergy Therapeutics News

2022-04-19 - Carolina Allergy Solutions

Carolina Allergy Solutions is thrilled to be able to bring Advanced Allergy Therapeutics (AAT) to the community and surrounding area.

2022-04-17 - Eye Allergy Therapeutics Market Size And Forecast | Allergan ...

Eye Allergy Therapeutics Market Size And Forecast | Allergan Plc, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co.

2022-03-30 - Allergy Therapeutics Selects AGC Biologics to Manufacture ...

We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$331.1M8769%N/A
#2
$637.5M1290N/AN/A
#3
$711.8M188310%N/A
#4
$854.4M27743%N/A
#5
$1104.9M29236%N/A